LPS is a molecule found in the outer membrane of Gram-negative bacteria. It is not an infectious organism itself, but the immune system recognizes it as a powerful danger signal. In laboratory research, LPS is commonly used to model aspects of bacterial infection or systemic inflammation. Its principal receptor is Toll-like receptor 4, or TLR4, which activates intracellular signaling pathways that stimulate the production of inflammatory mediators, including cytokines such as interleukin-1 beta, interleukin-6 and tumor necrosis factor. When this response occurs during a sensitive stage of brain development, it may affect neural circuits as they are being assembled.

The neonatal period is a particularly important biological window. The brain is undergoing rapid changes in synaptic connectivity, cellular maturation and communication between neurons and glial cells. Microglia, the resident immune cells of the central nervous system, help eliminate excess connections and support the refinement of developing neural networks. Inflammatory signals can alter these functions. An immune challenge that is temporary in the bloodstream may therefore influence processes in the brain that continue for weeks, months or even the entire lifespan of an experimental animal.

The new research focuses on the possibility that these consequences are not identical in the two sexes. Male and female brains differ in developmental timing, hormone exposure, immune regulation and patterns of microglial activity. Sex hormones can influence inflammatory signaling, while immune cells may respond differently to the same molecular stimulus depending on biological sex. These factors create the potential for a neonatal inflammatory event to redirect development along distinct trajectories, producing effects that might be subtle in one sex but more pronounced, persistent or behaviorally meaningful in the other.

The study’s central issue is not whether neonatal inflammation simply causes damage, but how it may reshape the relationship between the immune system and the developing nervous system. Inflammatory cytokines can influence the blood–brain barrier, modify neurotransmitter systems and change the growth or pruning of synapses. They may also affect the maturation of oligodendrocytes, the cells responsible for producing myelin, and alter communication between the brain and peripheral immune organs. Such changes could help explain why an early-life immune event might be associated with outcomes that emerge much later, even when no continuing infection is present.

This question has growing importance in the study of immune-mediated neurodevelopmental disorders. Conditions such as autism spectrum disorder, attention-deficit/hyperactivity disorder and some forms of schizophrenia involve complex interactions among genetics, brain development and environmental factors. Inflammation is not considered a single cause of these conditions, and an animal model cannot reproduce the full biology of a human disorder. However, research on developmental immune challenges may reveal mechanisms through which infection, inflammation or immune dysregulation increases vulnerability in individuals who already carry other biological risks.

The rat model allows researchers to examine long-term consequences under controlled conditions. Animals exposed to LPS shortly after birth can be followed across development, allowing investigators to compare immune, neurological and behavioral outcomes at later stages. Comparing males and females is essential because combining both sexes into one statistical group can conceal meaningful biological differences. A response that appears weak when averaged across an entire study population may become highly visible once sex-specific patterns are analyzed separately.

The findings described by Opallo and colleagues are especially relevant because they frame neonatal LPS exposure as a long-term, sex-dependent biological influence rather than a short-lived inflammatory episode. This perspective challenges the assumption that the end of an infection marks the end of its consequences. Early immune activation may leave behind changes in gene regulation, cellular responsiveness or neural circuitry that become apparent only when the brain encounters later developmental demands. Understanding these delayed effects could help researchers identify biomarkers of vulnerability and clarify why similar early-life exposures do not produce identical outcomes in every individual.

At the same time, the work should be interpreted with the caution required for preclinical research. The dose and timing of LPS used in rats may not correspond directly to an infection experienced by a human newborn, and behavioral changes in animals cannot be translated automatically into clinical diagnoses. Sex-specific findings in rodents also require confirmation in other models and in carefully designed human studies. Even so, the research provides a valuable framework for investigating how immune signals interact with developing neural systems. By placing biological sex at the center of that question, the study may help move neurodevelopmental research toward more precise explanations—and, eventually, more individualized strategies for prevention and treatment.

Subject of Research: Sex-specific long-term effects of neonatal lipopolysaccharide (LPS) exposure in rats and its relevance to immune-mediated neurodevelopmental disorders

Article Title: Sex-specific long-term effects of neonatal LPS exposure in rats: relevance for immune-mediated neurodevelopmental disorders

Article References: Opallo, N., Melini, S., Bove, M. et al. “Sex-specific long-term effects of neonatal LPS exposure in rats: relevance for immune-mediated neurodevelopmental disorders.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04359-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04359-x

Keywords: neonatal inflammation, lipopolysaccharide, LPS, rats, sex differences, neurodevelopment, microglia, immune-mediated disorders, brain development, cytokines

The researchers analyzed immune biomarkers rather than clinical diagnoses alone, using cytokines as a molecular window into the inflammatory milieu during gestation and the early postnatal period. Twins offer a distinctive design advantage: shared genetics and shared perinatal environments can help researchers separate background immune variation from differences that may correlate with later developmental trajectories.

In this pilot work, cytokine profiles measured from mothers and newborns were compared across relevant twin groupings. The central idea is that autism-related risk may not arise solely from genetic inheritance; instead, it may be shaped by subtle immune differences during a window when the fetal immune system and brain are especially sensitive to inflammatory cues.

Methodologically, the study relies on immunological quantification of circulating cytokines, enabling researchers to detect shifts in specific signaling pathways. Cytokines act as communication molecules between immune cells, and changes in their levels can suggest altered regulation of immune activation, tolerance, and inflammatory resolution.

Although the study is exploratory, the authors interpret their findings as evidence that perinatal immune biology may show measurable signatures in populations with autism risk. Such signatures could include deviations in pro- and anti-inflammatory balance, potentially affecting neurodevelopment through immune-to-brain signaling mechanisms.

Importantly, the results do not imply that inflammation is destiny. Instead, they support a more nuanced model in which immune variation contributes probabilistically, interacting with genetics and other environmental factors. The twin framework strengthens this interpretation by reducing some sources of confounding.

The work’s viral-news value lies in its emphasis on timing: immune signals during pregnancy and the newborn stage may be detectable in biomarker form long before any behavioral phenotype is observed. If validated in larger cohorts, cytokine profiling could become part of future risk stratification strategies.

For now, the study stands as an early immunological map—useful, testable, and designed to guide the next generation of research into how perinatal immune dysregulation may intersect with autism development.

Subject of Research: Perinatal immune dysregulation and autism risk assessed through maternal and neonatal cytokine profiles in a twin cohort.

Article Title: Maternal and neonatal cytokine profiles in a twin cohort: evidence from an exploratory pilot study of perinatal immune dysregulation in autism.

Article References: Imran, M.A., Mohebbi, M., Wright, C.R. et al. Pediatric Research (2026). https://doi.org/10.1038/s41390-026-05308-6

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05308-6

Keywords: Maternal cytokines; Neonatal cytokines; Twin cohort; Perinatal immune dysregulation; Autism.